A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
Clinical trial NCT02349061 · COMPLETED
Trial details
- NCT number
- NCT02349061
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-15
- Primary completion
- 2017-05-15
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.